CASM-dependent LRRK2 activation may also be relevant for Crohn’s disease, where human genetics has established roles for both ATG16L1 and LRRK2, and our data now place these genes into a common cellular pathway (Hampe et al., 2007; Van Limbergen et al., 2009). The gene discussed is LRRK2; the disease is Crohn disease.